Page last updated: 2024-11-01

nialamide and Ataxia

nialamide has been researched along with Ataxia in 1 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pálosi, E1
Mészáros, C1
Szporny, L1

Other Studies

1 other study available for nialamide and Ataxia

ArticleYear
Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
    Arzneimittel-Forschung, 1969, Volume: 19, Issue:11

    Topics: Amphetamine; Animals; Antidepressive Agents; Ataxia; Blood Pressure; Body Temperature; Catalepsy; Ca

1969